Expression of cancer/testis antigens in prostate cancer is associated with disease progression.
about
Molecular signaling involving intrinsically disordered proteins in prostate cancerCancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancerCancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of Prostate and Other CancersThe Stress-response protein prostate-associated gene 4, interacts with c-Jun and potentiates its transactivation.hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients.BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers.Autoantibodies to tumor-associated antigens in breast carcinoma.Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein.Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.Augmenting antitumor immune responses with epigenetic modifying agents.Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy.Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.Cancer/testis antigens and urological malignanciesCancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.Inducible expression of cancer-testis antigens in human prostate cancer.Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.Oncogenic cancer/testis antigens: prime candidates for immunotherapy.Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity.Cancer testis antigen and immunotherapy.Cancer/testis antigen PAGE4, a regulator of c-Jun transactivation, is phosphorylated by homeodomain-interacting protein kinase 1, a component of the stress-response pathway.A majority of the cancer/testis antigens are intrinsically disordered proteinsNanowire analysis of cancer-testis antigens as biomarkers of aggressive prostate cancer.Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cellsMelanoma antigen A12 regulates cell cycle via tumor suppressor p21 expression.Dr. Coffey's visionary contributions to urological research in China and Japan.Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.
P2860
Q26747089-B6645387-E84E-480B-9D46-B8B0F3AACFB2Q26852766-90471935-3487-44DF-9FA0-CD1180696E5AQ33624448-BFD98F8F-B596-4AC6-94CC-1154C89AF284Q33862856-60ED851E-264B-45B9-8D2F-4AAF010E1851Q33913833-4FB98B39-ACC6-4BB6-8A23-23AF8C7934A6Q34032518-CA3DE345-A793-4212-B22A-7185C3A14746Q34044914-657A102F-8D12-4F1E-9B09-753FC687C9F9Q34256170-6DEF9FA9-42B1-482B-AAF4-3E1E58EEE54EQ34339160-CA955396-051C-42A8-BB17-FA3965E080B8Q34632716-EAA6B428-9A04-41BA-9171-2C919435BA9CQ34799973-AD7F5A73-847E-4C89-AB03-664E585C0B61Q34870799-882E1E7F-2A59-4D6B-846A-BB1B94FB2DA7Q35048054-61ED0D7D-48BC-461B-ADCA-8C124FC356E9Q35249858-6A3CE52C-582D-4673-B6DC-C4F3403E8F80Q36075245-FCEF0292-7C39-499E-929D-74BC5376E5B0Q36337004-90CE170F-6806-430F-8D88-405C72CFC5E0Q36637039-0955BB69-48F8-4F13-9318-275820689DD2Q37046496-7302693D-6B03-4752-9976-66E9FC1F3EB3Q37222932-ADD72077-0619-4424-8A1D-978D58FD1C16Q37686238-3D3C6716-017E-4ACA-8188-8A96977A8693Q38212231-96BD78EF-E773-4049-8486-10106C522DF4Q38544350-701C951B-5511-4E8B-8FBD-748E36001BFEQ38910392-F4C27A65-4511-48A1-8092-238B27E847A5Q38912232-31DDA639-D260-4F04-B994-0E550EE8D920Q39021870-5EFD5268-A2C5-4D04-9D5F-97B8CC87FFC9Q39063386-D29F1667-5B38-46A6-8A25-48DD34A04BDDQ41496498-5F5917BC-DA88-4D81-839C-B560A276C7CFQ41682198-51C49112-96C8-4BF5-B6D1-8207EA5E7417Q42366622-2A1A2B43-ECEC-4CF6-B800-80C80969DD66Q55129496-408F54CB-71DA-43D6-A52A-EF28BA5C41CBQ55515702-2B43485C-3BD6-485F-B8F3-F7576B178D60
P2860
Expression of cancer/testis antigens in prostate cancer is associated with disease progression.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Expression of cancer/testis an ...... ated with disease progression.
@en
Expression of cancer/testis an ...... ated with disease progression.
@nl
type
label
Expression of cancer/testis an ...... ated with disease progression.
@en
Expression of cancer/testis an ...... ated with disease progression.
@nl
prefLabel
Expression of cancer/testis an ...... ated with disease progression.
@en
Expression of cancer/testis an ...... ated with disease progression.
@nl
P2093
P2860
P356
P1433
P1476
Expression of cancer/testis an ...... ated with disease progression.
@en
P2093
Nehal Parekh
Prakash Kulkarni
Robert H Getzenberg
Robert L Vessella
Takahito Suyama
Takumi Shiraishi
P2860
P304
P356
10.1002/PROS.21214
P577
2010-12-01T00:00:00Z